NO20101313L - Fremgangsmate for a hemme bakterievekst - Google Patents

Fremgangsmate for a hemme bakterievekst

Info

Publication number
NO20101313L
NO20101313L NO20101313A NO20101313A NO20101313L NO 20101313 L NO20101313 L NO 20101313L NO 20101313 A NO20101313 A NO 20101313A NO 20101313 A NO20101313 A NO 20101313A NO 20101313 L NO20101313 L NO 20101313L
Authority
NO
Norway
Prior art keywords
bacterial growth
inhibiting bacterial
inhibiting
infant formula
growth
Prior art date
Application number
NO20101313A
Other languages
English (en)
Norwegian (no)
Inventor
Bryon W Petschow
Original Assignee
Mead Johnson Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson Nutrition Co filed Critical Mead Johnson Nutrition Co
Publication of NO20101313L publication Critical patent/NO20101313L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20101313A 2008-06-03 2010-09-21 Fremgangsmate for a hemme bakterievekst NO20101313L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5824308P 2008-06-03 2008-06-03
PCT/US2009/042275 WO2009148730A1 (en) 2008-06-03 2009-04-30 Method for inhibiting the growth of bacteria

Publications (1)

Publication Number Publication Date
NO20101313L true NO20101313L (no) 2010-09-30

Family

ID=41380594

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20101313A NO20101313L (no) 2008-06-03 2010-09-21 Fremgangsmate for a hemme bakterievekst

Country Status (12)

Country Link
US (1) US9439885B2 (de)
EP (1) EP2280698A4 (de)
CN (1) CN102056601A (de)
BR (1) BRPI0909847A2 (de)
CA (1) CA2727054A1 (de)
CO (1) CO6321228A2 (de)
CZ (1) CZ2010892A3 (de)
MX (1) MX2010011054A (de)
NO (1) NO20101313L (de)
RU (1) RU2010154624A (de)
TW (1) TW201000031A (de)
WO (1) WO2009148730A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011081509A1 (es) * 2009-12-29 2011-07-07 Chavez Gabriela Composiciones nutricionales que comprenden hojuelas de frutas que incluyen ácido docosahexaenoico
MY162797A (en) 2010-12-29 2017-07-14 Abbott Lab Nutritional products including a novel fat system including monoglycerides

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298624A (en) 1970-10-16 1981-11-03 General Foods Corp. Protection against mite contamination
US4670285A (en) 1982-08-06 1987-06-02 The University Of Toronto Innovations Foundation Infant formula
US5270188A (en) 1985-02-06 1993-12-14 Amano Pharmaceutical Co., Ltd. Preparation of glycerides having a high content of monglycerides with a lipase from Penicillium cyclopium ATCC 34613
CA1331559C (en) 1986-04-21 1994-08-23 Jon Joseph Kabara Antimicrobial preservative compositions and methods
US5624958A (en) 1987-12-31 1997-04-29 Isaacs; Charles E. Disinfecting contact lenses
US4931300A (en) 1989-01-09 1990-06-05 Doyle W. Boatwright Antimicrobial food composition
JPH0394660A (ja) 1989-09-07 1991-04-19 Nippon Oil & Fats Co Ltd 粉末栄養組成物
JPH04197146A (ja) 1990-11-28 1992-07-16 Nippon Oil & Fats Co Ltd 米飯用抗菌剤
US5780039A (en) 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
US6699907B1 (en) 1996-02-20 2004-03-02 Westfaliasurge, Inc. Fatty acid antimicrobial
US6428832B2 (en) 1996-03-26 2002-08-06 Dsm N.V. Late addition of PUFA in infant formula preparation process
US5908862A (en) 1996-07-31 1999-06-01 Abbot Laboratories Water-miscible esters of mono--and diglycerides having antibacterial activity and their use in inhibiting infection
US5981587A (en) * 1996-07-31 1999-11-09 Abbott Laboratories Water-miscible esters of mono- and diglycerides having antimicrobial activity and their use in inhibiting infection
US5866606A (en) * 1996-07-31 1999-02-02 Abbott Laboratories Nutritional formulations containing water-miscible lipid derivatives as anti-microbial agents
US5958974A (en) 1996-07-31 1999-09-28 Abbott Laboratories Nutritional formulations containing water-miscible lipid derivatives as antibacterial agents
US6033705A (en) 1998-07-08 2000-03-07 Isaacs; Charles E. Method for treating foodstuffs to reduce or prevent microbial activity
US6077558A (en) 1998-12-23 2000-06-20 Bristol-Myers Squibb Company Elemental nutritional products
US6838431B2 (en) 1999-07-27 2005-01-04 Pacific Health Laboratories, Inc. Nutritional intervention composition containing a source of proteinase inhibitor extending post meal satiety
ATE362717T1 (de) 2000-01-31 2007-06-15 Nihon Starch Co Ltd Verfahren zur herstellung von lebensmitteln mit guter haltbarkeitsqualitaet sowie lebensmittelkonservierungsstoffe
MXPA03000359A (es) 2000-07-14 2003-05-27 Nestle Sa Lipidos de la dieta para mejorar la piel y el pelaje de mascotas.
US7070825B2 (en) 2002-09-10 2006-07-04 Abbott Laboratories Infant formula
WO2004050115A2 (en) * 2002-12-03 2004-06-17 Novo Nordisk A/S Combination treatment using exendin-4 and thiazolidinediones
US20050175759A1 (en) 2004-02-09 2005-08-11 Atul Singhal Newborn infant formulas and feeding methods
PL1638416T3 (pl) * 2003-06-23 2013-09-30 Nestec Sa Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
US7090879B2 (en) 2004-03-18 2006-08-15 Abbott Laboratories Nutritional formula containing select carotenoid combinations
EP1688049A1 (de) 2005-02-03 2006-08-09 findusFit Sportdiätetika GmbH Diätetisches Lebensmittel
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US8163320B2 (en) * 2006-07-13 2012-04-24 Nestec S.A. Stabiliser system for liquid nutritional compositions
US8722120B2 (en) * 2006-08-02 2014-05-13 Mead Johnson Nutrition Company Amino acid-based nutritional formulations

Also Published As

Publication number Publication date
WO2009148730A1 (en) 2009-12-10
CN102056601A (zh) 2011-05-11
RU2010154624A (ru) 2012-07-20
TW201000031A (en) 2010-01-01
BRPI0909847A2 (pt) 2015-10-06
US20090298937A1 (en) 2009-12-03
CZ2010892A3 (cs) 2011-11-09
CA2727054A1 (en) 2009-12-10
EP2280698A1 (de) 2011-02-09
CO6321228A2 (es) 2011-09-20
MX2010011054A (es) 2010-11-12
EP2280698A4 (de) 2011-08-24
US9439885B2 (en) 2016-09-13

Similar Documents

Publication Publication Date Title
CY1124333T1 (el) Συνθεσεις ποτου
TN2010000539A1 (en) Salts and polymorphs of a tetracylcline compound
NI201100223A (es) Derivados de imidazolidina 2 -0ne 1,3 - disustituidos como inhibidores de cyp 17
MX340533B (es) Derivados de 1,6- diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
DOP2011000102A (es) Compuestos heteroaromaticos espirociclicos fusionados para el tratamiento de infecciones bacterianas
NZ593111A (en) Antibacterial compounds
MX349718B (es) Compuestos antimicrobianos y metodos para fabricar y utilizar los mismos.
MX358682B (es) Derivados de pirazolo [1,5a]pirimidina y de tieno[3,2b] pirimidina como moduladores de la cinasa asociada al receptor de la interleucina 4 (irak4).
EP2675822A4 (de) Steroidalkaloidderivate und ihre verwendung als antimikrobielle mittel gegen mikroben mit elektronentransportmangel und als potenzierungsmittel für antimikrobielle wirkstoffe gegen krankheitserregende bakterien
MY174523A (en) ?-lactamase inhibitor and process for preparing the same
MY176900A (en) Antimicrobial compounds and methods of making and using the same
BR112013002957A2 (pt) composto de 1,4,5,6-tetrahidro-pirimidin-2-ilamina
CA2710814C (en) Bacterial ghost (bg) production process using betapropiolactone (blp) for final inactivation
PH12015502375B1 (en) Antimicrobial compounds and methods of making and using the same
SG10201900541QA (en) Derivatives of xanthone compounds
NZ596628A (en) Ketolide compounds having antimicrobial activity
MA32375B1 (fr) Derives de 5-hydroxymethyl-oxazolidine-2-one pour le traitement de maladies intestinales bacteriennes
IN2012DN03846A (de)
EP2421539A4 (de) Verfahren zur behandlung einer bakteriellen infektion der lunge mithilfe von fluorchinolonen
MY165011A (en) Antimicrobial compounds and methods of making and using the same
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
WO2015024011A3 (en) Antibacterial compounds
MX2012002299A (es) Uso de cetoenoles ciclicos contra bacterias fitopatogenas.
NO20101313L (no) Fremgangsmate for a hemme bakterievekst
MX2012004282A (es) Composiciones farmaceuticas.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application